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1. Introduction
Infectious disease results from the disruption of the balance between the host and the patho‐
gen. Pathogen influencing factors include virulence, immunoevasion capacities, and drug
resistance ability. According to the host, disease outcome relay on many factors such as: im‐
munocompetence, comorbidities, terrain (ageing, malnutrition).
The lung epithelium is a large surface exposed to outside aggression. The environment
plays a key role in the onset and development of illness by many factors such as: climate,
social and cultural habits, vegetations, degree of industrial, or domestic pollutions...
Despite this exaggerated exposition, the lung is nevertheless protected through non specific
and/ or specific defense mechanisms (Agostini CV, Chilosi M, Zambello R et al, 1993).
1.1. Non specific defense mechanisms
According to its size, a foreign substance can reach the upper or lower respiratory tract, and
be cleaned via the mucociliary escalator, during coughing or sneezing. Epithelial cells also
secrete many agents such as lysozyme, toxic oxygen radicals, with antimicrobial properties.
The renewal of the epithelium, as for the skin, is an additional protecting property.
Innate  immune recognition  is  a  second protective  mechanism implicating  immune cells
and secreted mediators. Its under the control of cells carrying receptors for recognition of
foreign antigens  (PRRs:  pathogen recognition receptors)  such as  macrophages,  dendritic
cells, neutrophils, mastocytes, epithelial cells, NK cells, and fibroblasts which can link mi‐
crobial  structures  (PAMPS:  pathogen associated  molecular  patterns)  for  further  destruc‐
tion (Ahnen DJ, 1985).
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1.2. Specific defense mechanisms
Adaptive immunity relays on the interaction between antigen-presenting cells (macrophag‐
es, dendritic cells, neutrophils) with specific T-lymphocytes in the context of cell mediated
immunity, as well as, on the antibodies production by activated B-lymphocytes (humoral
immunity) (Kohlmeter JE, Woodland DL, 2006).
2. Tropical parasitic lung diseases
2.1. Overview
Protozoa and helminthes can affect the lung as a primary site, or a complication. Some para‐
sites have a migration cycle through the lung (larva migrans), inducing blood and tissue eo‐
sinophilia. Tissue and peripheral blood eosinophilia are elicited by chimiotactic activity of
released inflammatory mediators, such as cytokines (IL-3, IL-5), which play a key role in ac‐
tivation and differentiation of eosinophils. Eosinophils secrete various substances, some
with antiparasitis properties, others favoring tissue damage in targeted organs. Elevated IgE
level observed in these conditions relay on the Th2-lymphocytes, stimulating antibodies
production by B-lymphocytes (Om P Sharma, 1991; VijayanVK, 2008).
Clinical manifestations of the lung involvement could be acute: asthma –like syndrome, or
Loeffler’s syndrome, with dyspnea, wheezing, cough (Ford RM, 1996); or chronic such as he‐
moptysis or right heart failure signs. Acute manifestations depend on immunological reac‐
tion (hypersensitivity), and chronic feature relay on the mechanical action of pathogen on
the vessels and tissues. (vg: schistosoma eggs in the pulmonary artery and pulmonary hy‐
pertension). (Santiago M et al., 2005).
Löeffler’s syndrome represent transient clinical, immunological and radiological manifesta‐
tions due to parasites whose life cycle elicit a transit through the lung or not, and to drug
reactions
Hypereosinophilia observed in this syndrome is antigen –induced, and circulating IL-5, is
the key mechanism for the recruitment and differentiation of the eosinophils.
2.2. Helminthic parasites
The three classes of helminths (Cestoidea, Trematoda, and Nematoda) can affect the lung.
2.2.1. Nematodes and the lung
This group include: ascariasis, strongyloidiasis,ancylostomiasis, tropical pulmonary eosino‐
philia, pulmonary dirofilariasis, and pulmonary trichinellosis.
2.2.1.1. Pulmonary ascariasis
Ascariasis is a round worm infection caused by Ascaris lumbricoides. This nematode dis‐
ease affects ± 25% of the world population whose 95% are in Africa (Crompton, 1999).
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Mode of contamination
The starting point is the survival of eggs able to contaminate ingesta by the new host. Poor
sanitation, fecal contamination of food or water, are the main risk factors of dissemination.
Embryonated eggs (2-4 weeks), when ingested are dissolved in the stomach juice and then
release rabdoid larvae in the duodenum, before migration through the intestine. Larvae then
enter the portal system via capillaries and lymphatics, after penetrating the wall of the intes‐
tine. The involvement of the hepatic circulation allow the right heart and lung invasion. The
eggs reach the alveolar space after crossing the capillary walls and can be swallowed and
then reach again the small intestine to mute in adult forms. This pilgrimage can take 14 days
after ingestion (Sarinas PS, Chitkara RK, 1997).
Pathophysiology
Adult worms or migrating larvae exert a mechanical pressure on lung structures inducing
inflammatory responses, leading to granuloma formation with eosinophils, neutrophils and
macrophages. Activated cells release cytokines such as IL-3 and IL-5 involved in the recruit‐
ment and differenciation of eosinophils, explaining the blood and tissue eosinophilia report‐
ed. TH2 Lymphocytes are responsible for the high IgE (Yazicioglia, 1996) and IgG4 levels
(Santra A, 2001) described.
Hypersensitivity reaction inducing peribronchial inflammation, mucus production, and
sometimes bronchospasm is responsible for the clinical manifestations.
Diagnosis
Abdominal manifestations are currently reported: gastric pain, vomiting, diarrhea, abdomi‐
nal discomfort. In some complicated cases pancreatitis or obstruction of biliary duct or small
intestine can occur, caused by adult worms.
Respiratory symptoms due to larval migration in the lungs, consist in mild cough or Loef‐
fler’s syndrome (Ford RM, 1996). This syndrome associates respiratory symptoms (dry
cough, wheezing, dyspnoea) with blood and lung eosinophilia, and chest radiograph with
fleeting infiltrates. General symptoms such as fever, loss of appetite, myalgia can be ob‐
served.
Pneumonia is a more rare condition with ascariasis infection
Laboratory findings
Stool examination may show eggs or adult worms.
Larvae may be found in respiratory secretions
Serological approach (specific IgG4 antibodies) could be helpful (Santra A et al., 2001; Bhat‐
tacharya T, 2001).
Blood hypereosinophilia and high IgE level are common.
Chest radiograph may show migrating inhomogenous alveolar infiltrates.
Treatment
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The treatment aims to eradicate intestinal colonization responsible for recurrent respiratory
episodes.
Mebendazole (100 mg twice a day for three days, or 500mg one day) and Albendazole
(400mg, single dose) are the drugs of choice. Pyrantel Pamoate, Levamisole, and Piperazine
are alternative choices. Ivermectine, an antifilarial drug has shown efficacy in the treatment
of ascariasis.
2.2.1.2. Toxocariasis
a roundworm of dog and cat can infect human, who is an intermediate host, and determine
a Loeffler’s like syndrome caused by larva migrans as with Ascaris.
Severe respiratory syndromes (ARDS) have rarely been observed (Bartelink AK et al., 1983),
while asthma-like symptoms are currently reported among pulmonary manifestations.
Defects in neutrophil function have been reported in children with visceral larva migrans.
This defect should be explained by the neutrophilic adherence to larvae illustrated else‐
where in animal models (Martin Huwer, 1989).
Exacerbations of inflammatory reactions during antihelminthic treatment emphasize the
need of combination with corticosteroids.
2.2.1.3. Pulmonary strongyloidiasis
The causative agent is Strongyloides stercoralis, endemic in the tropics and subtropics. Eggs
containing larvae ready to hatch, are the contaminating form after penetrating the skin; they
then disseminate in all tissues via venous or lymphatic route in immunodeficient host
(Cook, 1987; Longworth and Weller, 1986).
Autoinfestation is a common feature of this parasite, meaning the penetration of filariform
larvae in the perianal skin of the infected subject without leaving the host. This phenomenon
can determine the persistence of infection even many years after (Scowden EB, 1978).
Lung invasion result from larvae carried by the blood stream to the right heart and then to
the lung. Larvae can pierce the pulmonary capillaries and reach the alveoli through the al‐
veolo-capillary membrane, inducing non cardiogenic edema and hemoptyses. After their
migration through the bronchi and superior respiratory tree, some larvae can be swallowed
in the intestine. Hyperinfection syndrome is related to severity of symptoms in the lung and
the intestine, which are common sites of the parasitic life cycle, while disseminated disease
represent the invasion of other organs not generally involved in the growth of the parasite
(Longoworth DL, and Weller PF, 1986).
Pathophysiology
The skin penetration by the larva determines an hypersensitivity reaction as the result of a
strong cell mediated immunity reaction in immunocompetent host preventing the tissue in‐
vasion (Neva FA, 1986). Marked autoinfection and subsequent hyperinfection are the main
determinants of tissue dissemination in immunosuppressed subjects such as AIDS patients
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(Lessman KD, 1993), individuals on long term corticosteroid therapy, or with malnutrition,
lymphomas etc..(Casati A, 1996; Genta RM, 1989).
Mechanical action by the adult worms and host reaction are responsible for digestive mani‐
festations.
Secondary gram negative bacterial infection by gram- pathogen is frequent, bacteria being
carried by larvae during the crossing of the intestinal wall. The migration through the lung
can determine bronchopneumonia,alveolar hemorrhages, and pulmonary abscess and hae‐
moptyses.
Diagnosis
Lung strongyloidiasis is commonly asymptomatic in immunocompetant individuals, or
present with mild symptoms.
Gastrointestinal manifestations, cough, dyspnoea, wheezing and haemoptysis are frequent
during lung involvement. Hyperinfection and disseminated disease are commonly fatal,
which elderly individuals and those on long term corticosteroid therapy, or having hemato‐
logic malignancies being at higher risk for the latter.
Eosinophilic pleural effusion have been reported among pulmonary manifestations of
strongyloidiasis; and rare cases of acute respiratory failure due to respiratory muscle paraly‐
sis have been observed (da Silva OA, 1981).
The hyperinfection syndrome with Strongyloides stercoralis can worsen asthma or COPD
exacerbations in some patients (Sen P, 1995; Ossorio MA, 1990).
Peripheral  blood  eosinophilia,  anemia,  and  hypoalbuminemaia  are  current  laboratory
findings.
Larva may be observed in repeted stool specimen examination due to the low parasitic load
in immunocompetent individuals.
Pulmonary secretions, duodenal juice, may be contributive for parasite identification.
Serology is also interesting for detection of specific antibodies.
Treatment
Thiabendazole (25 mg/kg, twice a day for two days), Albendazole (400 mg, twice a day/5
days), Ivermectine (200 microgr/kg for one or two days) are recommended.
2.2.1.4. Pulmonary ancylostomiasis
Ancylostoma duodenale and Necator americanus are the two helminths in this group.
Eggs eliminated with the feces continue the maturation in the soil, where larvae will pene‐
trate the intact skin to infect the man, which is the only definitive host. The oral route of in‐
fection is possible for Ancylostoma duodenale. Migrant larvae reach the lung structures has
illustrate for other helminths, inducing a Loeffler’s syndrome. The larvae of Ancylostoma du‐
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odenale can reach the mammary glands and be transmitted to the child by maternal breast-
feeding (Yu Sen-Hai, 1995).
Pathophysiology
The lung migration can elicit blood eosinophilia as for other larva migrans. Larvae release
low molecular weight proteins with anticoagulant properties (Cappello M, 1993), favoring
blood loss during the intestinal capillaries destruction. Anemia with iron deficiency is often
associated with this infection.
Local prurit and erythema follow skin penetration. Clinical, immunological and radiologi‐
cal  manifestations  of  Loeffler’s  syndrome  can  be  observed  during  larval  migration
through the lung.
Diagnosis
Gastrointestinal symptoms associated with respiratory asthma-like symptoms in an exposed
individual are suggestive of parasitic lung infections
Laboratory findings
Stool examination may demonstrate the presence of eggs, blood samples may identify eosi‐
nophilia and iron deficient anemia.
Treatment
Mebendazole and Albendazole have equivalent efficacy.
Ivermectine has been reported as an alternative.
2.2.1.5. Tropical Pulmonary Eosinophilia (TPE)
This syndrome is an immunological response of the host to filarial parasites invasion, main‐
ly Wuchereria bancrofti and Brugia malayi, affecting only 1% of patients with filariasis
(Johnson S, 1994).
The filarial etiology has been suggested by the prevalent occurrence of the syndrome in the
world regions with reported high filarialsis prevalence (South-East Asia), as well as the re‐
covery after antifilarial drug administration.
Pathophysiology
The hypersensitivity reaction to filarial antigens induce a strong eosinophilic inflammatory
response in the lungs. The microfilariae in lymphatics invade the pulmonary circulation and
parenchyma with further granulomatous and fibrosing pattern. The concentration of eosino‐
phils in the lung has been shown to be more significant than in the peripheral blood sug‐
gesting the compartimentalisation, and a prominent role of these cells in the pulmonary
involvement and clinical manifestations (Pinkstori P, 1987).
Diagnosis
Epidemiological data state a male predominance in TPE (sex ratio M/F; 4:1), a disease of
children and young adult (15-40 yrs).
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Respiratory manifestations are frequently associated with systemic symptoms such as: fever,
weight loss, and fatigue.
The diagnosis should be evoked after exclusion of other causes of pulmonary eosinophilia
as other helmintic diseases, or drug use.
Laboratory findings
Leucocytosis is common in TPE, with marked peripheral blood eosinophilia; and elevated
erythrocyte sedimentation rate is often reported.
Serological examinations may reveal high level of specific IgG or IgE antibodies to microfi‐
lariae.
Stool examination is very important to determine co-infection with other helminths.
The chest radiograph may show miliairy nodules mimicking miliairy tuberculosis.
Histopathological analysis of lung biopsies may illustrate microfilariae
Treatment
Diethylcarbamazine (6 mg/kg/day for 3 weeks), a current treatment of filariasis, has been
successfully indicated In patients with TPE.
Steroids have shown additional improvement of symptoms in TPE patients.
2.2.1.6. Pulmonary dirofilariasis
This is a zoonosis caused by Dirofilaria immitis and repens. The nematode is a vascular par‐
asite, with the human as accidental host. The parasite is transmitted by mosquito. The vas‐
cular location induce embolism of pulmonary artery, with subsequent pathophysiological
manifestations such as: hemoptyses, chest pain, dyspnoea …
The disease is mainly asymptomatic
Thoracic imaging (TTDM) shows well delimited nodule neigbouring an arterial branch.
Histopathological analysis of pulmonary biopsies is strongly contributive for the diagnosis
of this disease lacking specific treatment.
2.2.1.7. Pulmonary Trichinellosis
The food-borne disease is caused by Trichinella spiralis in the man.
The larvae grow in striated muscles after invading the bloodstream. Man is infected after in‐
gesting partially or cooked or raw meat, and the larvae develop in the gut into adult worms.
Pulmonary symptoms include: dyspnoea due partially to the involvement of diaphragm,
and cough.
Peripheral blood eosinophilia and elevated IgE level are depending on Th-2 cytokines re‐
leased by TCD4 cells recruited by parasitic antigens. Elevated LDH enzyme suggest muscle
involvement.
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Larvae may be also identified in striated muscle biopsies.
Treatment
Mebendazole (for almost 2 weeks), associated to analgesics and corticosteroids is recom‐
mended.
2.2.1.8. CESTODES and the lung
Lung disease due to cestodes are caused by Echinococcus granulosis and Echinococcus multilo‐
cularis in the man. The lung and the liver are the main sites of cysts formation. Dogs are de‐
finitive hosts and eggs excreted in their faeces contaminate human when ingested with food
or water.
Pulmonary symptoms are non specific and resemble asthma manifestations. Mechanical
compression by hydatid cysts may influence clinical features. Rupture of Cysts in the bron‐
chi could explain haemoptysis or excretion of cyst fluid, and may lead to anaphylaxis. Pneu‐
mothorax, pleural effusion, and emphysema are possible lung presentation.
Blood laboratory findings extend from eosinophilia to IgE production.
Serodiagnosis is helpful by detection of specific antibodies.
Chest radiograph manifestations may consist in multiple nodules mimicking lung tumors.
Treatment
Surgical resection of the lesion is the most relevant approach. Mebendazole, Albendazole
and praziquantel are indicated, mainly in recurrent disease.
2.2.1.9. Trematodes and the lung
This group include pulmonary scistosomiasis and paragonimiasis.
Pulmonary Shistosomiasis
Schistosoma haematobium, mansoni, and japonicum are the major pathogenic species for hu‐
man. Shistosoma intercalatum and Shistosoma mekongi are rarely encountered. Eggs excreted in
urine or faeces of the infected patient contaminate water and infect the snail, intermediate
host. The eggs then evolve in cercariae wich can penetrate the skin or be ingested by man.
The adult worm stay in the bladder (haematobium), or in the gut (S. mansoni, S. japonicum).
Pathophysiology
Local inflammation occurs at the penetration site, while the onset of pulmonary manifesta‐
tions may be acute or chronic.
Pulmonary inflammatory reaction may induce a cytotoxic reaction to migrating agents, and
facilitate the secretions of chimiotactic mediators for eosinophils, involved in the schistosoma
immunity (Schwartz E et al, 2000).
Acute manifestations result from immunologic hypersensitivity reactions, and consist of
systemic complaints such as fever, myalgia, chills, diarrhea, abdominal pain, urticaria,
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named Katayama syndrome. Pulmonary acute manifestations mimic Loffler’s syndrome or
Asthma-like syndrome (Walt F., 1954).
Chronic manifestations result from mechanical action of eggs or adult worm on the tissues.
Pulmonary hypertension, haemoptysis, cor pulmonale could be observed. Pulmonary embo‐
lism is the consequence of small blood vessels obstruction by foreign bodies surrounded by
various cells (eosinophils, neutrophils, lymphocytes, giant multinucleated cells (Wyler and
Postlehwaite WE, 1983); Granuloma formation is the end-stage of the maintained inflamma‐
tory response to schistosomal antigens.
Optic microscopical identification of eggs in urine or stools is mandatory for the diagnosis.
Rectal or bladder’s mucosal biopsies could help demonstrating eggs of Schistosoma.
Extrapulmonary manifestations include hepatosplenomegaly due to portal hypertension.
Schistosomiasis is an infectious cause of liver cirrhosis.
Peripheral blood eosinophilia and high IgE level are frequent.
Treatment
Cortcosteroides are indicate during acute phase and praziquantel (10-15 mg/kg, each 12
hours, one day). Artemether has shown effectiveness on juvenile forms of schistosomes.
Pulmonary Paragonimiasis
The food-borne zoonosis is more frequent in Asia, affecting± 20 million people (Schwartz E,
2002); Subacute or chronic lung manifestations are described. The agent Paragonimus west‐
ermani lives in the lung, and eggs are eliminated in the sputum or faeces. Miracidiae devel‐
op into cercariae in the snail before infecting the second intermediate host, the crabs. The
man get infection after eating partially cooked or raw crabs.
Clinical manifestations are not specific, and chest radiograph may demonstrate cavitations
as in tuberculosis. Pleural effusion or pneumothorax are frequently seen in paragonimiasis.
Treatment
Praziquantel is the first choice for treatment of this helminthic disease.
2.3. Protozoal lung diseases
2.3.1. Pulmonary amoebiasis
Entamoeba histolytica is the pathogenic form of infectious agent for the man.
Lung involvement is mainly linked to extension of amoebic liver abscess; hematogenous
spread and aspiration have rarely been reported (Shamsuzzaman SM et al, 2002).
During intestinal transit and mutations, Trophozoites released after the cysts digestion by
digestive secretions, may reach the muscularis mucosa and erode the lymphatics or the
walls of mesenteric venules to invade the portal system of the liver. The parasitic embols
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then obstruct the bloodstream and lead to abscess development with necrosis. The lung is
the most frequent site of extra-intestinal invasion.
Clinical symptoms are related to the hepatic and intrathoracic implications. General symp‐
toms including fever, right upper quadrant pain, cough, chest pain are frequent in the lung
amoebiasis. Pleural effusion could develop, following hepatobronchial fistula. The paren‐
chymal disease can present as pulmonary abscess with characteristic chocolate pus and air‐
space consolidation at chest radiograph. Elevation of right hemidiaphragm is an earlier
radiographical feature in liver abscess.
E histolytica may be identified in sputum, in stools specimen or pleural pus.
The accuracy of serodiagnosis is established in the tissue amoebiasis, mainly in non endemic
populations. PCR should also be more contributive, even not routinely performed in many
institutions.
Treatment
Metronidazole is widely used, with established effectiveness. Lactoferrin and lactoferricins
combined to low metronidazole doses has been proposed as an alternate therapeutic option.
2.3.2. Pulmonary malaria
Malaria is a public health problem in tropical and subtropical areas. With the increasing
population travelling, mosquitos which transmit the disease can be carried out of the natural
frontiers and cause illness in naïve, non exposed patients. Four species of Plasmodium are
identified (P falciparum, P. ovale, P. malariae, P. vivax). Plasmodium falciparum, vivax, and ovale
can cause acute lung injury, or acute respiratory distress syndrome (Mohan A et al, 2008).
Pathophysiology
The pathogen lives in the erythrocytes and could impair their functions. Impaired red cells
motility, favored by exaggerated cytoadherence to the capillaries endothelium (Corbett CE
et al, 1989), induce sequestration of the red and white blood cells in different organs, with
subsequent deprivation in oxygen delivery, endothelial dysfunction, and enhancement of
anaerobic metabolism. Multiple organ dysfunctions (MODS) is the condition leading to
death. Red cells sequestration and destruction enhances the release of parasites and erythro‐
cyte material in the bloodstream, inducing a vigorous inflammatory response
Pulmonary involvement extend from cough and dyspnoea, to fatal ARDS, non cardiogenic
pulmonary edema, and intra-alveolar hemorrhages. Parenchymal disease due to plasmodial
infections has not yet been clearly evidenced, due to numerous viral or bacterial co-infec‐
tions, mainly in child under 5 years.
ARDS in malaria is more common in adults than in children, as well as in pregnant women
and non immune individuals
The pathogenesis of ARDS in severe malaria is poorly understood. Sequestration of parasi‐
tized red cells in small vessels seems not to be the only underlying mechanism. Recent study
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in Indonesia has reported occurrence of ARDS in uncomplicated and severe malaria, in pa‐
tients within the first 5 days after the start of the treatment, while peripheral parasitemia
was decreased. The authors hypothesize that lung injury could then be related to an inflam‐
matory response following treatment (Louis Schofield, Georges E. Grau, 2005). Their work
suggest that impaired lung function is not exclusively the fact of microvascular obstruction
by parasitized red cells, but include also white blood cells, contributing to impairment of gas
transfer, subsequent to ventilation and perfusion mismatch (Anstey NM et al, 2002).
Pulmonary edema follows increased alveolar capillary permeability with extravasation of
capillary content into the alveoli (Mohan Alladi et al, 2008)
Diagnosis
Systemic symptoms of malaria are: fever, myalgia, headache, loss of appetite, nausea, vomit‐
ing. Severe respiratory symptoms may be observed, following the onset of edema and respi‐
ratory distress syndrome.
Thick and thin stained blood smears are the routine laboratory examination to identify the
plasmodium species.
Serodiagnosis and PCR of plasmodium in urine or saliva, may be contributive where available.
Chest radiograph demonstrates variable patterns such as lobar consolidation, pleural effu‐
sion, alveolar infiltrates suggesting pulmonary edema, or hemorrhages.
Treatment
Parenteral quinine is the drug of 1st choice for the treatment of severe malaria. Artemisinine
derivatives are an alternative in case of contra-indications. Adjunctive therapy with clinda‐
mycine or doxycycline has been proposed in complicated malaria.
General resuscitation measures could be indicated in life threatening cases.
Antivectorial eradication, using insecticide treated bed-nets is widely utilized in endemic re‐
gions.
2.3.3. Pulmonary Toxoplasmosis
The disease caused by the Protozoan parasite, Toxoplasma gondii infects the man, after inges‐
tion of cyst-contaminated food.
Immunocompromised individuals are at higher risk of developing toxoplasmosis with the
central nervous system involvement as the most common complication.
Toxoplasma infection is asymptomatic in most immunocompetent humans. The pathogen is
then destroyed by strong antibody dependent reactions or delayed type hypersensitivity
mechanism. A strong Th1 cytokine profile is elicited by cells of innate immunity for efficient
protection, and pathogen could be destroyed also by monocytes- derived mediators such as
nitric oxide, which inhibits the parasite growth in different organs, mainly the lung and the
central nervous system, as prominent targets.
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Diagnosis
Encephalitic symptoms are very contributive for the diagnosis of toxoplasmosis in HIV posi‐
tive patients. Pneumonitis occurring in less than 1% of AIDS cases may induce septic shock.
Tissue biopsy should be very important for an early diagnosis
Cervical or occipital lymphadenopathy are the common clinical feature with flu-like symp‐
toms. Target organs involved are: the brain, the liver, the lung, the muscle, the heart, the
eyes, with related symptoms. Pulmonary symptoms may resemble tuberculosis, or severe
Pneumocystis jiroveci pneumonia
Reactivation of latent infection is frequent in immunosuppressed patients (AIDS, organ
transplantation).
2.3.4. Pulmonary Trypanosomiasis
Trypanosoma cruzi, the etiological agent of trypanosomiasis is frequent, as Chagas disease,
in Central and South America. Man is infected through the bite of an insect, inoculating try‐
pomastigotes which multiply within the macrophages. Macrophages then release amasti‐
gotes, the invading form of tissues through bloodstream. The heart and the gut are the most
involved organs with predominant clinical manifestations (myocarditis, arythmia, achalasia,
megacolon). Pulmonary manifestations (pleural effusion, edema), are linked to heart in‐
volvement. Tracheomegaly and bronchiectasis have been infrequently encountered (Lemle
A. Chagas’ disease, Chest 1999; 115, 906). Acute manifestations consist of flu-like syndrome
and facial edema.
Serological diagnosis is helpful in chronic forms.
3. Conclusion
The internalization of neglected tropical diseases due to migrations across the world high‐
lights the awareness of healthcare givers. The diagnosis of parasitic tropical pulmonary dis‐
ease could be evoked in recent travelers or immigrants from endemic zones, presenting with
respiratory symptoms with peripheral blood or tissue eosinophilia.
Author details
Ntumba Jean-Marie Kayembe*
Address all correspondence to:
Department of Internal Medicine, University of Kinshasa, Democratic Republic of Congo
Oncogenesis, Inflammatory and Parasitic Tropical Diseases of the Lung154
References
[1] Agostini, C. V., Chilosi, M., Zambello, R., et al. (1993). Pulmonary immune cells in
health and diseases: lymphocytes. Eur Respir J, 6, 1378-1401.
[2] Ahnen, D. J., Brown, W. R., & Kloppel, D. J. (1985). Secretory component: the poly‐
meric immunoglobulin receptor. Gastroenterology, 89, 667-682.
[3] Kohlmeter, J. E., & Woodland, D. L. (2006). Memory Tcell recruitment to the lung air‐
ways. Curr Opin Immunol, 18, 352-362.
[4] (1991). Lung Disease in the Tropics. Lung Biology in Health and Disease, Marcel
Dekker Inc, , 51, 1-20.
[5] Vijayan, V. K. (2008). Tropical parasitic lung diseases. Indian J Chest Dis Allied Sci, 50,
49-66.
[6] Ford R.M. (1996). Transient pulmonary eosinophilia and asthma: a review of 20 cases
occurring in 5702 asthma sufferers. Am Rev Respir Dis, 93, 797-803.
[7] Santiago, M., Santiago, R., Jorge, A., Carrillo, Sonia. L., et al. (2005). Thoracic Mani‐
festations of Tropical Parasitic Infections. A Pictorial Review. Radiographics, 25,
135-155.
[8] Crompton D.W.T. (1999). How much human helminthiasis is there in the world? Par‐
asitol, 85, 379-403.
[9] Sarinas, P. S., & Chitkara, R. K. (1997). Ascariasis and hookworm. Scmin Respir Infect,
12, 130-137.
[10] Yazicioglia, M., Ones, U., & Yalcin, I. (1996). Peripheral and nasal eosinophilia and
serum total immunoglobulin E levels in children with ascariasis. Turk J Pediatric, 38,
477-484.
[11] Santra, A., Bhattacharya, T., Chowdhury, A., Ghosh, A., Ghosh, N., Chatterjee, B. P.,
et al. (2001). Serodiagnosis of ascariasis with specific IgG4 antibody and its use in ep‐
idemiological study. Trans R Soclhp Med Hyg, 95, 289-292.
[12] Bhattacharya, T., Santra, A., Mazumdar, D. N., & Chatterjee, B. P. (2001). Possible ap‐
proach for serodiagnosis of ascariasis by evaluation of immunoglobulin G4 response
using Ascaris lumbricoides somatic antigen. J Clin Microbiol, 39, 2991-2994.
[13] Bartelink, A. K., Kortdek, L. M., Huldekoper, H. G., Meulenlt, J., & Van Knapen, F.
(1983). Acute respiratory failure due to toxocara infection. Lancet, 342, 1234.
[14] Martin, Huwer., Sabine, Sanft., Jabbar, S., & Ahmed, . (1989). Enhancement of neutro‐
phil adherence to toxocara canis larvae by the C3 component of complement and IgG
antibodies. Medical Microbiology, Infectious Diseases, Virology, Parasitology, 270(3),
418-423.
Tropical Lung Diseases
http://dx.doi.org/10.5772/52371
155
[15] Cook, G. C. (1987). Strongyloides stercoralis hyperinfection syndrom how often is it
mist. Q J Med, 64, 625-629.
[16] Longworth L.L. and Weller, P.F. (1986). Hyperinfection syndrom with strongyloidia‐
sis. Current Clinical Topics in Infectious Diseases, edited by JC Remington and MN
Swartz, New-York Mc Graw-Hill,, 27-50.
[17] Scowden, E. B., Schaffner, W., & Stone, W. J. (1978). Overwhelming strongyloidiasis:
anunappreciaed opportunistic infection. Medicine, (Baltimore), 57, 527-544.
[18] Longoworth D.L. and Weller P.F. (1986). Hyperinfection syndrome with strongyloi‐
diasis. In current clinical topics in infectious diseases. Editer by JS Remington and
NM Swartz, New-York, McGraw-Hill,, 27-50.
[19] Neva F.A. (1986). Biology and immunology of human strongyloidiasis. J Infect Dis,
153, 397-406.
[20] Lessmanl, C. D., Can, S., & Talavera, W. (1993). Disseminated Strongyloides stercora‐
lis in human immunodeficiency virus-infected patients: treatment failure and review
of literature. Chest, 104, 119-122.
[21] Casati, A., Cornero, G., Muttini, S., Tresoidi, M., Gaulioli, G., & Torri, G. (1996). Hy‐
peracute pneumonitis in a patient with overwhelming Strongyloides stercoralis in‐
fection. Eur J Anesthesiol, 13, 498-501.
[22] Genta, R. M., Miles, P., & Fieids, K. (1989). Opportunistic Strongyloides stercoralis in‐
fection in lymphoma patients: report of a case and review of the literature. Cancer, 63,
1407-1411.
[23] da, Silva. O. A., Amarol, da., Silveira, J. C., Lopez, M., & Pittella, J. E. (1981). Hypoka‐
lemic respiratory muscle paralysis following Strongyloides stercoralis hyperinfec‐
tion: a case report. Am Trop Med Hyg, 30, 69-73.
[24] Sen, P., Cil, C., Estrellas, B., & Middleton, J. R. (1995). Corticosteroid- induced asth‐
ma: a manifestation of limited hyperinfection syndrome due to Strongyloidesstereor‐
alis. South Mcd J, 88, 923-927.
[25] Ossorio M.A., Brovon Pil, Fields CL, Roy T.M. (1990). Exacerbation of chronic ob‐
structive pulmonary disease due to hyperinfection with Strongyloides stercoralis. J
Ky Med Assoc, 88, 233-237.
[26] Yu Sen-Hai, Jiang Ze-xiao, Xu Long-Qi. (1995). Infantile hookworm disease in China:
a review. Acta Trop, 59, 265-270.
[27] Cappello, M., Clyne, L. P., Mac, Phedram. P., & Hotez, P. J. (1993). Ancylostoma fac‐
tor Xa inhibitor: partial purification and Us identification as a major hookworm-de‐
rived anticoagulant in Malaria is caused by the obligate iutraerythrocytic in vitro. J
Infect Dis, 167, 1474-1477.
[28] Johnson, S., Wilkinson, R., & Davidson, . (1994). Tropical respiratory medicine. IV:
Acute tropical infection and the lung. Thorax, 49, 714-718.
Oncogenesis, Inflammatory and Parasitic Tropical Diseases of the Lung156
[29] Pinkstori, P., Vijayan, V. K., Nutman, T. B., Rom, W. N., O’Donnelli, K. M., Cornelius,
et., & al, . (1987). Acute tropical pulmonary eosinophilia: characterization of the low‐
er respiratory tract inflammation and its response to therapy. J Clin Invest, 80,
216-225.
[30] Schwartz, E., Rozenman, J., & Prelman, N. (2000). Pulmonary manifestation of early
schistosoma infection in non immune travelers. Am J Med, 109, 718-722.
[31] Walt, F. (1954). The katayama syndrome. S Afr Med J, 28, 89-93.
[32] Wyler D.J. and Postlehwaite W.E.(1983). Fibroblast stimulation in schistosomiasis. IV,
Isolated egg granulomas elaborated a fibroblast chemoattractant in vitro. J Immu‐
nol. , 130, 1371-1375.
[33] Schwartz, E. (2002). Pulmonary schistosomiasis. Clin Chest Med, 23, 433-443.
[34] Shamsuzzaman, S. M., & Hashiguchi, Y. (2002). Thoracic amebiasis. Clin Chest Med ,
23, 479-492.
[35] Mohan, A. K., Sharma, S., & Bollineni, S. (2008). Vector Borne Dis , 45, 179-193.
[36] Corbett, Duarte. M. I., Lancello, H. C. L., Silva, Andrade., & Junior, H. F. (1989). Cy‐
toadherence in human Falciparum malaria as a cause of respiratory distress. J Trop
Med Hyg, 92, 112-120.
[37] Louis, Schofield., Georges, E., & Grau, . (2005). Immunological processes in malaria
pathogenesis. Nature Reviews Immunology, September, 5, 722-735.
[38] Anstey, N. M., Jacups, S. P., Cain, T., et al., & 200, . (2002). Pulmonary manifestations
of uncomplicated Falciparum and Vivax malaria, cough, small airways obstruction,
impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis, 185,
1326-1334.
[39] Lemle, A. (1999). Chaga’s disease. Chest 115: 906.
Tropical Lung Diseases
http://dx.doi.org/10.5772/52371
157

